Revolutionizing Diabetes Care with Innovative Long-Term Glucose Monitoring Solutions.

A pioneering force in the healthcare industry, this company is renowned for its development of the first long-term implantable continuous glucose monitoring (CGM) system. Their flagship product, the Eversense CGM system, employs a miniaturized sensor implanted under the skin. This sensor communicates with a smart transmitter worn above the skin, relaying glucose levels, related trends, and alerts straight to the user's mobile device. This innovation provides a significant advancement in diabetes management by offering up to 180 days of continuous glucose monitoring from a single sensor insertion, setting a new standard compared to other CGM systems on the market.

The company's mission is devoted to enhancing diabetes therapy and management by seamlessly integrating glucose monitoring solutions into connected healthcare systems. Through their commitment to research and innovation, they provide individuals with diabetes the essential tools they need to manage their condition with greater freedom and peace of mind. Headquartered in Montgomery County, Maryland, the company continues to expand its global market presence, contributing significantly to the diabetes care landscape and setting pathways for future advancements in healthcare technology.